Ruvolo, Vivian

Results of the Phase I trial of RG7112, a small-molecule MDM2 antagonist in leukemia

Andreeff, M., Kelly, K. R., Yee, K., Assouline, S., Strair, R., Popplewell, L., Bowen, D., Martinelli, G., Drummond, M. W., Vyas, P., et al. (2016) · Clinical Cancer Research

Cancer-related Molecular PathwaysAcute Myeloid Leukemia Research

Cited by 352

Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy

Pan, R., Ruvolo, V., Mu, H., Leverson, J. D., Nichols, G., Reed, J. C., Konopleva, M., & Andreeff, M. (2017) · Cancer Cell

Cell death mechanisms and regulationCancer-related Molecular Pathways

Cited by 300

PKR Regulates B56α-mediated BCL2 Phosphatase Activity in Acute Lymphoblastic Leukemia-derived REH Cells

Ruvolo, V. R., Kurinna, S. M., Karanjeet, K. B., Schuster, T. F., Martelli, A. M., McCubrey, J. A., & Ruvolo, P. P. (2008) · Journal of Biological Chemistry

Cell death mechanisms and regulationProtein Kinase Regulation and GTPase Signaling

Cited by 48